As of May 27
| +0.15 / +0.12%|
The 3 analysts offering 12-month price forecasts for USANA Health Sciences Inc have a median target of 159.00, with a high estimate of 160.00 and a low estimate of 135.00. The median estimate represents a +31.13% increase from the last price of 121.25.
The current consensus among 3 polled investment analysts is to Buy stock in USANA Health Sciences Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.